320 related articles for article (PubMed ID: 28054407)
21. Modulation of collagen synthesis in keloid fibroblasts by silencing Smad2 with siRNA.
Gao Z; Wang Z; Shi Y; Lin Z; Jiang H; Hou T; Wang Q; Yuan X; Zhao Y; Wu H; Jin Y
Plast Reconstr Surg; 2006 Nov; 118(6):1328-1337. PubMed ID: 17051103
[TBL] [Abstract][Full Text] [Related]
22. Effect of the abrogation of TGF-beta1 by antisense oligonucleotides on the expression of TGF-beta-isoforms and their receptors I and II in isolated fibroblasts from keloid scars.
Bran GM; Goessler UR; Schardt C; Hormann K; Riedel F; Sadick H
Int J Mol Med; 2010 Jun; 25(6):915-21. PubMed ID: 20428796
[TBL] [Abstract][Full Text] [Related]
23. Adenoviral overexpression and small interfering RNA suppression demonstrate that plasminogen activator inhibitor-1 produces elevated collagen accumulation in normal and keloid fibroblasts.
Tuan TL; Hwu P; Ho W; Yiu P; Chang R; Wysocki A; Benya PD
Am J Pathol; 2008 Nov; 173(5):1311-25. PubMed ID: 18832570
[TBL] [Abstract][Full Text] [Related]
24. Tacrolimus fails to regulate collagen expression in dermal fibroblasts.
Wong VW; You F; Januszyk M; Kuang AA
J Surg Res; 2013 Sep; 184(1):678-90. PubMed ID: 23647800
[TBL] [Abstract][Full Text] [Related]
25. Non-coding RNAs as direct and indirect modulators of epigenetic mechanism regulation of cardiac fibrosis.
Tao H; Yang JJ; Shi KH
Expert Opin Ther Targets; 2015 May; 19(5):707-16. PubMed ID: 25652534
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic mechanisms in Parkinson's disease.
Feng Y; Jankovic J; Wu YC
J Neurol Sci; 2015 Feb; 349(1-2):3-9. PubMed ID: 25553963
[TBL] [Abstract][Full Text] [Related]
27. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts.
Wang Y; Fan PS; Kahaleh B
Arthritis Rheum; 2006 Jul; 54(7):2271-9. PubMed ID: 16802366
[TBL] [Abstract][Full Text] [Related]
28. Genetic susceptibility to raised dermal scarring.
Brown JJ; Bayat A
Br J Dermatol; 2009 Jul; 161(1):8-18. PubMed ID: 19508304
[TBL] [Abstract][Full Text] [Related]
29. Promoted activation of matrix metalloproteinase (MMP)-2 in keloid fibroblasts and increased expression of MMP-2 in collagen bundle regions: implications for mechanisms of keloid progression.
Imaizumi R; Akasaka Y; Inomata N; Okada E; Ito K; Ishikawa Y; Maruyama Y
Histopathology; 2009 May; 54(6):722-30. PubMed ID: 19438747
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic mechanisms in Alzheimer's disease: implications for pathogenesis and therapy.
Wang J; Yu JT; Tan MS; Jiang T; Tan L
Ageing Res Rev; 2013 Sep; 12(4):1024-41. PubMed ID: 23688931
[TBL] [Abstract][Full Text] [Related]
31. The antimicrobial peptides psoriasin (S100A7) and koebnerisin (S100A15) suppress extracellular matrix production and proliferation of human fibroblasts.
Gauglitz GG; Bureik D; Zwicker S; Ruzicka T; Wolf R
Skin Pharmacol Physiol; 2015; 28(3):115-23. PubMed ID: 25502330
[TBL] [Abstract][Full Text] [Related]
32. A novel regulatory function for miR-29a in keloid fibrogenesis.
Zhang GY; Wu LC; Liao T; Chen GC; Chen YH; Zhao YX; Chen SY; Wang AY; Lin K; Lin DM; Yang JQ; Gao WY; Li QF
Clin Exp Dermatol; 2016 Jun; 41(4):341-5. PubMed ID: 26566758
[TBL] [Abstract][Full Text] [Related]
33. microRNA deregulation in keloids: an opportunity for clinical intervention?
Yu X; Li Z; Chan MT; Wu WK
Cell Prolif; 2015 Dec; 48(6):626-30. PubMed ID: 26486103
[TBL] [Abstract][Full Text] [Related]
34. Atherosclerosis Is an Epigenetic Disease.
Xu S; Pelisek J; Jin ZG
Trends Endocrinol Metab; 2018 Nov; 29(11):739-742. PubMed ID: 29753613
[TBL] [Abstract][Full Text] [Related]
35. Expression profile and bioinformatics analyses of circular RNAs in keloid and normal dermal fibroblasts.
Zhang Z; Yu K; Liu O; Xiong Y; Yang X; Wang S; Zhang S; Feng Y; Peng Y
Exp Cell Res; 2020 Mar; 388(1):111799. PubMed ID: 31904383
[TBL] [Abstract][Full Text] [Related]
36. Differential regulation of PAI-1 gene expression in human fibroblasts predisposed to a fibrotic phenotype.
Higgins PJ; Slack JK; Diegelmann RF; Staiano-Coico L
Exp Cell Res; 1999 May; 248(2):634-42. PubMed ID: 10222156
[TBL] [Abstract][Full Text] [Related]
37. Botulinum toxin A for the treatment of keloids.
Gauglitz GG; Bureik D; Dombrowski Y; Pavicic T; Ruzicka T; Schauber J
Skin Pharmacol Physiol; 2012; 25(6):313-8. PubMed ID: 22948093
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of collagen synthesis by IWR-1 in normal and keloid-derived skin fibroblasts.
Zhou MW; Yin WT; Jiang RH; Lee JH; Kim CD; Lee JH; Zhu MJ; Yoon TJ
Life Sci; 2017 Mar; 173():86-93. PubMed ID: 27939785
[TBL] [Abstract][Full Text] [Related]
39. 3D modeling of keloid scars in vitro by cell and tissue engineering.
Suttho D; Mankhetkorn S; Binda D; Pazart L; Humbert P; Rolin G
Arch Dermatol Res; 2017 Jan; 309(1):55-62. PubMed ID: 27942931
[TBL] [Abstract][Full Text] [Related]
40. [Some aspects of molecular bases of keloid formation].
Pastuszak-Gabinowska M; Peregud-Pogorzelski J; Łuksza K; Sznelewski P; Brodkiewicz A
Ann Acad Med Stetin; 2011; 57(2):10-7. PubMed ID: 23002663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
